C12N15/1082

Molecular fabrication

Provided herein is a method for fabricating transformable or transfectable molecules that includes an assembly reaction containing a variety of pre-made cassettes possessing ends that hybridize to one another, transforming or transfecting said molecules into a desired host cell and then selecting a transformed/transfected host cell containing plasmid molecules composed of said the cassettes. A kit for performing the method is also provided.

Methods and compositions for studying cell evolution

The subject matter disclosed herein is generally directed to methods and compositions for tagging cells of interest, tracking evolution of the tagged cells, and recovering the original tagged cells for further study. Specifically, cells are tagged with a DNA construct encoding a barcode sequence comprising a guide sequence. Barcoded cells can then be recovered using a reporter construct having CRISPR target sequences specific for the cell having a barcode of interest.

Method for evaluating multiple different genes of interest

It is an object of the present invention to provide, for instance, a method for evaluating a function, such as transforming potential, of multiple different genes of interest, and a method capable of evaluating drug sensitivity of a subject having each gene of interest. The present invention relates to, for instance, a method for evaluating multiple different genes of interest, comprising the steps of: integrating, into host cell genomic DNA, polynucleotides each comprising a tag sequence and a gene of interest or a fragment thereof linked to the tag sequence; mixing a plurality of different host cells having the different polynucleotides integrated therein; culturing the mixed host cells; extracting the genomic DNA from the cultured host cells; quantifying each of the polynucleotides in the extracted genomic DNA based on the tag sequence; and determining a relative cell count of each of the host cells having the respective polynucleotides after the culturing, based on the quantified values for the polynucleotides.

METHOD OF ENABLING POOLED-LIBRARY BASED NUCLEIC ACID CONSTRUCTS SCREENING
20220411788 · 2022-12-29 ·

The present invention relates to a method of enabling pooled-library based nucleic acid constructs screening in insect cells.

BACTERIAL ENGINEERING

Described is a process for producing a mutant bacterium which exhibits improved survival and/or growth under a selected growth condition, the process comprising the steps of: (a) generating a pool of mutant bacteria by transposon mutagenesis with an activating transposon (TnA), wherein the TnA comprises a promoter capable of increasing transcription of a gene at or near its insertion site; (b) growing bacteria from the mutant pool under the selected growth condition and under one or more reference conditions to produce two or more test cultures; and (c) comparing the distribution of TnA insertions between test cultures to identify a first class of genes which are disadvantageous for growth and/or survival under the selected growth condition and a second class of genes which are advantageous for growth and/or survival under the selected growth condition.

Multiplex end-tagging amplification of nucleic acids

The present disclosure provides a method for assembly of genomic DNA using multiplex end-tagging amplification of genomic fragments.

Multiplex end-tagging amplification of nucleic acids

The present disclosure provides a method for assembly of genomic DNA using multiplex end-tagging amplification of genomic fragments.

METHYLATION DETECTION AND ANALYSIS OF MAMMALIAN DNA
20220389412 · 2022-12-08 ·

The present disclosure provides a method for methylation analysis of genomic fragments.

METHYLATION DETECTION AND ANALYSIS OF MAMMALIAN DNA
20220389412 · 2022-12-08 ·

The present disclosure provides a method for methylation analysis of genomic fragments.

COMPOSITIONS AND METHODS COMPRISING VIRAL VECTOR SYSTEMS FOR MULTIPLEXED ACTIVATION OF ENDOGENOUS GENES AS IMMUNOTHERAPY AND VIRAL-BASED IMMUNE-GENE THERAPY
20220387626 · 2022-12-08 ·

The present invention includes compositions and methods comprising viral vector systems for multiplexed activation of endogenous genes as immunotherapy and viral-based immune-gene therapy.